NEW YORK, Oct. 31, 2016 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of Spectrum Pharmaceuticals, Inc. (“Spectrum Pharmaceuticals”) (NASDAQ:SPPI) between December 16, 2015 and September 16, 2016.
You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the District of Nevada. If you purchased or otherwise acquired Spectrum Pharmaceuticals between December 16, 2015 and September 16, 2016, your rights may be affected by this action. To get more information go to:
http://www.zlk.com/pslra/spectrum-pharmaceuticals-inc
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
The Complaint alleges that throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Food and Drug Administration (the "FDA") questioned whether the data from the 611 and 612 Studies were clinically significant; (2) the FDA informed defendants in December 2012 not to submit the New Drug Application based on data from the 611 and 612 Studies; and (3) accordingly, defendants' public statements concerning the Company's business, operations and prospects were materially false and misleading at all relevant times.
If you suffered a loss in Spectrum Pharmaceuticals you have until November 21, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation involving financial fraud, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com


China Vanke Seeks Bond Extension Amid Mounting Debt Crisis
China's AI Stocks Surge as Zhipu and MiniMax Hit Record Highs
MATCH Act: How New U.S. Chip Legislation Could Freeze China's Semiconductor Ambitions
Bendigo and Adelaide Bank Posts Strong Q3 Earnings, Announces AI-Driven Job Cuts
Pilots Fear Retaliation for Refusing Middle East Flights Amid Ongoing Conflict
Anthropic's Mythos AI Model Sparks Emergency Cybersecurity Meeting With Top U.S. Bank CEOs
SanDisk Joins Nasdaq-100, Replacing Atlassian on April 20
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58%
OpenAI Addresses Security Vulnerability in macOS App Certification Process
Alibaba Shares Slide as Jefferies Slashes Price Target Over AI Spending and Business Losses
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization
U.S. Automakers Push Back Against EU Rules Blocking American Trucks from European Market
Bill Ackman Eyes New Fund to Bet Against Market Complacency
Chinese Brands Are Taking Over Brazil — And It's Just Getting Started
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit 



